Is Micron a Buy Under $900? The CXMT Fear Is Now 30% of the Price

TL;DR

• Yes. The fear is legitimate and the discount now overpays it.
• MU trades around $877.57, about 30% below its 52-week high of $1,255, in a year when its product went into physical shortage.
• The Street's arithmetic disagrees with the tape: the average of 41 analyst targets sits near $1,502, and UBS carries $1,625, both predicated on HBM mix holding.
• The bear case has a name: CXMT, China's DRAM champion, whose capacity ramp is the reason a shortage-year stock trades below $900.

Is Micron a Buy Under $900?

Yes, and the shape of the argument matters: this is a case where both sides are right about the facts and the price decides who is right about the stock. The bears are correct that CXMT is real, state-funded, and ramping DRAM capacity into exactly the commodity tiers where Micron earns its cyclical floor. That threat is why MU broke below $900 in the first place. The bulls are correct that the HBM tier, where the AI money actually is, remains a three-player game that CXMT has not cracked, that the broader memory shortage runs to 2028 on Samsung's own estimate, and that a 30% discount during a shortage is historically what buying opportunities look like.

What tips it: time horizons. CXMT eroding the commodity floor is a 2027-2028 problem arriving on China's construction schedule. The HBM shortage paying Micron is a now problem, compounding every quarter it persists. A stock priced 30% below its high for a threat two years out, while the tailwind is current, has its discounting backwards, and the sell side's $1,502 average, whatever its usual optimism, is measuring that same gap.

The Bear Rejoinder

Memory investors carry scar tissue for a reason: every cycle, the "this time the moat holds" argument shows up right before it does not. If CXMT reaches viable HBM years early, or if AI capex pauses while new supply lands, MU is a commodity producer at the wrong end of a capacity wave and $877 is not the floor. The stock has already shown what that repricing feels like, cratering after record earnings once this year.

So the call comes with its tripwire attached: the position is long under $900 with conviction, on a 12-month horizon (the site's own call, basis: HBM scarcity outlasting the commodity-tier erosion), and the exit condition is verifiable, not vibes. Any credible demonstration of CXMT HBM at volume, or a Micron guide that walks down HBM mix, and the thesis is over regardless of price.

The One-Line Read

Micron under $900 is a stock discounted 30% for a Chinese threat that arrives in 2027 while being paid today by a shortage that runs to 2028: the call is buy, with the CXMT-reaches-HBM headline as the one tripwire that ends it.